Clear Street’s Envoy Medical COCH Stock Holding History

Clear Street’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-127,000	Closed	-$891K	–	869
2023 Q3	$891K	Buy	127,000 +126,440	+22,579%	+$1.27M	0.02%	97
2023 Q2	$5.73K	Buy	+560	New	+$5.66K	﹤0.01%	792
2022 Q4	–	Sell	-702	Closed	-$7K	–	1080
2022 Q3	$7K	Buy	+702	New	+$6.89K	﹤0.01%	699
2022 Q1	–	Sell	-3,456	Closed	-$34K	–	457
2021 Q4	$34K	Buy	+3,456	New	+$33.7K	﹤0.01%	130

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clear Street's COCH Position: Q4 2023 in Review

Clear Street sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 127,000 shares — an estimated $891K sold.

Clear Street first reported a position in COCH in Q4 2021 and held it in 4 quarters. The position peaked at $891K in Q3 2023. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

Clear Street reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
Clear Street sold 127,000 Envoy Medical shares in Q4 2023, an estimated $891K.
Clear Street first reported a position in Envoy Medical in Q4 2021 and held it in 4 quarters.
Clear Street's Envoy Medical position peaked at $891K in Q3 2023.
9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Clear Street's 13F filing for Q4 2023, filed 14 Feb 2024.